~~<i id='7308EBCB30'><strike id='7308EBCB30'><tt id='7308EBCB30'><pre id='7308EBCB30'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：Wikipedia 2025-09-29 01:08:26 - browse：2

Adam's take main illustration — Molly Ferguson/STAT

Biotech is awash in PIPEs.

The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Medicare bonuses could stop drug shortages under Senate plan

knowledge

Wikipedia

explore

knowledge

entertainment

focus

AdobeLastfall,theWorldHealthOrganizationandsomenationaldrugregulatorsurgedinfluenzavaccinemanufactur

WSS

Ahead of JPM, here's who's profiting most in health care

Prior authorization reform is both possible and imperative

White House finalizes ITC's import ban of latest Apple Watches

There's an unseen cost to disruptive road

Inaction leaves children at risk from dangerous chemotherapy drug

Why psychiatrists like me stop taking insurance

focus

hotspot

knowledge

Duchenne breakthrough therapy leaves behind pioneering families

Head of FDA's diagnostics center, who led through Covid, retires

As demand for Covid shots wanes, Moderna seeks its next success

AdventHealth escalates lawsuit against insurance vendor Multiplan

How one medical school became remarkably diverse

How a scoliosis diagnosis changed the life of one young dancer

In age of alternative facts, a scholarly course on calling out crap

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Affirmative action in medical school literally saved lives

The FDA must approve intranasal treatments for anaphylaxis

Wikipedia

What causes osteoarthritis? Researchers study link to brain protein

Feng Zhang CRISPR delivery startup lays off quarter of staff

Flu vaccine reformulation won't be easy, manufacturers warn

Antibiotic resistance and the global rise in human conflict

Inaction leaves children at risk from dangerous chemotherapy drug

Antibiotic resistance and the global rise in human conflict

explore

knowledge

entertainment

focus